Identification Of 2-Pmpa As A Novel Inhibitor Of Cytosolic Carboxypeptidases

Ruixue Wang,Lianyun Lin,Yiqiang Zheng,Peng Cao,James I Moragn,Zhiguang Yuchi,Hui-Yuan Wu
DOI: https://doi.org/10.1016/j.bbrc.2020.10.029
IF: 3.1
2020-01-01
Biochemical and Biophysical Research Communications
Abstract:Cytosolic carboxypeptidases (CCPs) comprise a unique subfamily of M14 carboxypeptidases and are erasers of the reversible protein posttranslational modificationpolyglutamylation. Potent inhibitors for CCPs may serve as leading compounds targeting imbalanced polyglutamylation. However, no efficient CCP inhibitor has yet been reported. Here, we showed that 2-phosphonomethylpentanedioic acid (2PMPA), a potent inhibitor of the distant M28 family member glutamate carboxypeptidase II (GCPII), rather than the typical M14 inhibitor 2-benzylsuccinic acid, could efficiently inhibit CCP activities. 2PMPA inhibited the recombinant Nna1 (a.k.a. CCP1) for hydrolyzing a synthetic peptide in a mixed manner, with Ki and Ki' being 0.11 mu M and 0.24 mu M respectively. It inhibited Nna1 for deglutamylating tubulin, the best-known polyglutamylated protein, with an IC50 of 0.21 mM. Homology modeling predicted that the R-form of 2-PMPA is more favorable to bind Nna1, unlike that GCPII prefers to S-form. This work for the first time identified a potent inhibitor for CCP family. (C) 2020 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?